Animal models of human herpesvirus infection
Authors:
Open Access
- 7 February 2025
- journal article
- review article
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (4) , 615-628
Abstract
Human herpesvirus, a specific group within the herpesvirus family, is responsible for a variety of human diseases. These viruses can infect humans and other vertebrates, primarily targeting the skin, mucous membranes, and neural tissues, thereby significantly impacting the health of both humans and animals. Animal models are crucial for studying virus pathogenesis, vaccine development, and drug testing. Despite several vaccine candidates being in preclinical and clinical stages, no vaccines are current available to prevent lifelong infections caused by these human herpesviruses, except for varicella‐zoster virus (VZV) vaccine. However, the strict host tropism of herpesviruses and other limitations mean that no single animal model can fully replicate all key features of human herpesvirus‐associated diseases. This makes it challenging to evaluate vaccines and antivirals against human herpesvirus comprehensively. Herein, we summarize the current animal models used to study the human herpesviruses including α‐herpesviruses (herpes simplex virus type 1(HSV‐1), HSV‐2, VZV), β‐herpesviruses (human cytomegalovirus (HCMV), γ‐herpesviruses (Epstein–Barr virus (EBV)) and Kaposi's sarcoma herpesvirus (KSHV)). By providing concise information and detailed analysis of the potential, limitations and applications of various models, such as non‐human primates, mice, rabbits, guinea pigs, and tree shrews, this summary aims to help researchers efficiently select the most appropriate animal model, offering practical guidance for studying human herpesvirus.Keywords
Funding Information
- National Natural Science Foundation of China (82222041, 82241068)
- Natural Science Foundation of Beijing Municipality (Z220018)
This publication has 199 references indexed in Scilit:
- A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral ChallengesAdvanced Materials, 2023
- Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal ScreeningJAMA Network Open, 2021
- Development of Cytomegalovirus-Mediated Sensorineural Hearing Loss in a Guinea Pig ModelJAMA Otolaryngology–Head & Neck Surgery, 2010
- A new animal model for primary and persistent Epstein–Barr virus infection: Human EBV‐infected rabbit characteristics determined using sequential imaging and pathological analysisJournal of Medical Virology, 2008
- Murine gammaherpesvirus‐68 infection of mice: A new model for human cerebral Epstein–Barr virus infectionAnnals of Neurology, 2005
- Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virusJournal of Medical Virology, 2003
- In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD)Reviews in Medical Virology, 1999
- Natural history, management and complications of herpes labialisJournal of Medical Virology, 1993
- Ocular Varicella-Zoster Virus Infection in the Guinea PigArchives of Ophthalmology (1950), 1989
- Cell‐mediated immunity to varicella‐zoster virus infection in strain 2 guinea pigsJournal of Medical Virology, 1987